Related Experiment Video
Updated: Mar 14, 2026
Zika Virus Infectious Cell Culture System and the In Vitro Prophylactic Effect of Interferons
Published on: August 23, 2016
Zika: an old virus with a new face
Tatjana Avšic Županc1, Miroslav Petrovec1
1University of Ljubljana, Faculty of Medicine, Institute of Microbiology and Immunology, Zaloška 4, 1000 Ljubljana, Slovenia.
Abstract:
Zika virus is a mosquito-borne flavivirus that represents a public health emergency at the ongoing epidemic. This obscure virus was limited to sporadic cases in Africa and Asia, until the emergence of Zika virus in Brazil in 2015, when it rapidly spread throughout the Americas. Most Zika virus infections are subclinical or characterized by mild febrile illness. However, neurological complications, including Guillain-Barré syndrome in adults, and congenital anomalies, including microcephaly in babies born to infected mothers, raised a grave concern. Currently, there is no specific antiviral treatment or vaccine available for Zika virus infection. Thus, international public health response is primarily focused on preventing infection, particularly in pregnant women, and on providing up-to-date recommendations to reduce the risk of non-vector transmission of Zika virus.
Insights
Zika virus, a mosquito-borne flavivirus, caused a global health emergency after spreading from Brazil. The virus poses risks of neurological issues and congenital anomalies, with no current vaccine or treatment.
Area of Science:
- Virology
- Epidemiology
- Public Health
Background:
- Zika virus (ZIKV) is a mosquito-borne flavivirus previously confined to Africa and Asia.
- An outbreak in Brazil in 2015 led to rapid ZIKV spread across the Americas, causing a public health emergency.
- While often asymptomatic or mild, ZIKV infection is linked to severe neurological complications like Guillain-Barré syndrome and congenital anomalies such as microcephaly.
Purpose of the Study:
- To summarize the emergence and impact of Zika virus.
- To highlight the neurological and congenital risks associated with Zika virus infection.
- To outline current public health strategies for Zika virus prevention and control.
Main Methods:
- Literature review of Zika virus epidemiology and clinical manifestations.
- Analysis of public health responses and recommendations for Zika virus.
- Synthesis of information on ZIKV's transmission, risks, and prevention.
Main Results:
- Zika virus emerged in Brazil in 2015, spreading rapidly throughout the Americas.
- Neurological complications (e.g., Guillain-Barré syndrome) and congenital anomalies (e.g., microcephaly) are significant concerns.
- No specific antiviral treatments or vaccines are currently available for Zika virus.
Conclusions:
- The Zika virus epidemic necessitates a focus on infection prevention, especially for pregnant women.
- Public health efforts are concentrating on recommendations to minimize non-vector transmission.
- Continued vigilance and research are crucial for managing Zika virus risks.
